Chemed Corporation (NYSE: CHE) reported Q4 EPS of $3.35, $0.09 better than the analyst estimate of $3.26. Revenue for the quarter came in at $458 million versus the consensus estimate of $460.5 million.

GUIDANCE:

Chemed Corporation sees FY2019 EPS of $12.65-$12.85, versus the consensus of $12.54.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.